Clinipace expands global CRO ops with Paragon takeover

The ongoing consolidation of the CRO industry continued today as Clinipace Worldwide announced it will absorb Paragon Biomedical's operations. Morrisville, NC-based Clinipace says it will now double in size to more than 430 staffers worldwide. "With complementary strengths, we're thrilled to be combining forces with Clinipace Worldwide to create one globally integrated company," commented Gena Reed, founder and CEO of Paragon Biomedical. "Moreover, the company cultures and senior leadership teams blend well, creating a corporate marriage that is ideal for our employees and customers." Release